Arquitectura de información para la gestión de la historia clínica digital en oftalmopediatría

Introduction: the Medical History is a tool that contains the information of patients, which should able to be processed, stored and transmitted in a safe and accessible way, thus it is necessary to use resources and strategies to facilitate healthcare services, among which software designs can be included.Objective: to develop the information architecture for the management of an computerized medical record to be used in the Pediatric Ophthalmology Office at Pepe Portilla  Provincial Pediatric Teaching Hospital in Pinar del Rio.Methods: a qualitative-quantitative study was conducted, applying theoretical and empirical methods to analyze the evolution and development of a pediatric-ophthalmological history, to characterize the current situation, as well as the introduction of information and communication technologies into this specialty in Cuba.Results: the design of a prototype of software for the management of a computerized medical record in the Pediatric Ophthalmology Office, with a great social impact for the healthcare institutions where the system is implemented, which benefit both the patient and the professionals.Conclusion: the implementation of a computerized tool is a strategic decision that can simplify work, optimize time and resources, improving organizational process, management and safety.Introducción: la Historia Clínica es un instrumento que contiene la información del paciente que debe ser procesable, almacenada y trasmitida de forma segura y accesible, por lo que resulta necesario el empleo de recursos y estrategias para facilitar el cuidado de la salud, entre las que puede figurar un software.Objetivo: desarrollar la arquitectura de información para la gestión de una historia clínica electrónica para uso en la consulta de Oftalmopediatría del Hospital Pediátrico Provincial Docente “Pepe Portilla” de Pinar del Río.Métodos: estudio cuali-cuantitativo, con métodos teóricos y empíricos para analizar la evolución y desarrollo de la historia clínica de Oftalmopediatría, caracterizar la situación actual, así como la introducción de las tecnologías de la información y las comunicaciones en esta disciplina en Cuba.Resultados: se creó un prototipo de software de gestión de historia clínica electrónica en Oftalmopediatría, con un gran impacto social para las entidades donde se implemente el sistema, que beneficia tanto al paciente como a los profesionales.Conclusión: la implementación de una herramienta informática es una decisión estratégica que puede simplificar el trabajo, optimizar tiempo, recursos, y mejorar en organización, gestión y seguridad

Coats disease

Introducción: La enfermedad de Coats es una vasculopatía retiniana idiopática, poco frecuente, que puede progresar a desprendimiento de retina exudativo y glaucoma neovascular. Típicamente se presenta en la infancia, es la tercera causa más frecuente de leucocoria infantil.Presentación de caso: Paciente masculino de dos años de edad, procedente de zona rural. Asiste a consulta, porque la mama notó que el niño desvía el ojo derecho hacia fuera desde que nació.Conclusiones: La enfermedad de Coats simula otras vasculopatías retinianas y el retinoblastoma. La conducta a seguir dependerá de la, forma clínica de presentación y complicaciones asociadas.Introduction: Coats disease is a rare, idiopathic retinal vasculopathy that can progress to exudative retinal detachment and neovascular glaucoma. Typically occurring in childhood, it is the third most common cause of childhood leukocoria.Case report: Patient masculine of two years of age, coming from rural area. You attended consultation, because he/she suckles her he/she noticed that the boy deviates the right eye toward it was since he was born.Conclusions: Coats disease simulates other retinal vasculopathies and retinoblastoma. The behavior to be followed will depend on the clinical form of presentation and associated complications

Enfermedad de coats

Introduction: Coats disease is a rare, idiopathic retinal vasculopathy that can progress to exudative retinal detachment and neovascular glaucoma. Typically occurring in childhood, it is the third most common cause of childhood leukocoria.Case report: Patient masculine of two years of age, coming from rural area. You attended consultation, because he/she suckles her he/she noticed that the boy deviates the right eye toward it was since he was born.Conclusions: Coats disease simulates other retinal vasculopathies and retinoblastoma. The behavior to be followed will depend on the clinical form of presentation and associated complications.Introducción: La enfermedad de Coats es una vasculopatía retiniana idiopática, poco frecuente, que puede progresar a desprendimiento de retina exudativo y glaucoma neovascular. Típicamente se presenta en la infancia, es la tercera causa más frecuente de leucocoria infantil.Presentación de caso: Paciente masculino de dos años de edad, procedente de zona rural. Asiste a consulta, porque la mama notó que el niño desvía el ojo derecho hacia fuera desde que nació.Conclusiones: La enfermedad de Coats simula otras vasculopatías retinianas y el retinoblastoma. La conducta a seguir dependerá de la, forma clínica de presentación y complicaciones asociadas

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Background: Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without causing significant sodium retention. We report the long-term effects of treatment with atrasentan on major renal outcomes. Methods: We did this double-blind, randomised, placebo-controlled trial at 689 sites in 41 countries. We enrolled adults aged 18–85 years with type 2 diabetes, estimated glomerular filtration rate (eGFR)25–75 mL/min per 1·73 m 2 of body surface area, and a urine albumin-to-creatinine ratio (UACR)of 300–5000 mg/g who had received maximum labelled or tolerated renin–angiotensin system inhibition for at least 4 weeks. Participants were given atrasentan 0·75 mg orally daily during an enrichment period before random group assignment. Those with a UACR decrease of at least 30% with no substantial fluid retention during the enrichment period (responders)were included in the double-blind treatment period. Responders were randomly assigned to receive either atrasentan 0·75 mg orally daily or placebo. All patients and investigators were masked to treatment assignment. The primary endpoint was a composite of doubling of serum creatinine (sustained for ≥30 days)or end-stage kidney disease (eGFR <15 mL/min per 1·73 m 2 sustained for ≥90 days, chronic dialysis for ≥90 days, kidney transplantation, or death from kidney failure)in the intention-to-treat population of all responders. Safety was assessed in all patients who received at least one dose of their assigned study treatment. The study is registered with ClinicalTrials.gov, number NCT01858532. Findings: Between May 17, 2013, and July 13, 2017, 11 087 patients were screened; 5117 entered the enrichment period, and 4711 completed the enrichment period. Of these, 2648 patients were responders and were randomly assigned to the atrasentan group (n=1325)or placebo group (n=1323). Median follow-up was 2·2 years (IQR 1·4–2·9). 79 (6·0%)of 1325 patients in the atrasentan group and 105 (7·9%)of 1323 in the placebo group had a primary composite renal endpoint event (hazard ratio [HR]0·65 [95% CI 0·49–0·88]; p=0·0047). Fluid retention and anaemia adverse events, which have been previously attributed to endothelin receptor antagonists, were more frequent in the atrasentan group than in the placebo group. Hospital admission for heart failure occurred in 47 (3·5%)of 1325 patients in the atrasentan group and 34 (2·6%)of 1323 patients in the placebo group (HR 1·33 [95% CI 0·85–2·07]; p=0·208). 58 (4·4%)patients in the atrasentan group and 52 (3·9%)in the placebo group died (HR 1·09 [95% CI 0·75–1·59]; p=0·65). Interpretation: Atrasentan reduced the risk of renal events in patients with diabetes and chronic kidney disease who were selected to optimise efficacy and safety. These data support a potential role for selective endothelin receptor antagonists in protecting renal function in patients with type 2 diabetes at high risk of developing end-stage kidney disease. Funding: AbbVie

El glaucoma primario de ángulo abierto, caracterización clínica en Pinar del Río

Introduction: primary open-angle glaucoma is the most common type and represents the second cause of irreversible blindness, being a complex and heterogeneous disease.Objective: to characterize from the clinical point of view the patients who attended the provincial clinic of glaucoma during January 2017-December 2018.Methods: cross-sectional, descriptive study. A total of 1447 patients were examined at the provincial clinic of glaucoma, with the diagnosis of primary open-angle glaucoma in the period January 2017-December 2018.Results: 67,3 % of the patients studied belonged to the age group of 60-80 years old and 70 % were male. The 37,8 % were people of mixed race, the 68,7 % presented a mild glaucoma and 89,8 % had a visual acuity between 1,0-0,3;  68,7 % of the patients had an ocular pressure below 21 mmHg; 75,2 % of the patients had a disease evolution time of more than 5 years and 89,4 % underwent medical treatment.Conclusions: primary open-angle glaucoma was more frequent in advanced ages, in males and in people of mixed race. The majority had good visual acuity and a better correction in their best eye and normal ocular pressure. Mild glaucoma prevailed, with an evolution time of more than 5 years and with medical treatment for the control of the disease.Introducción: el glaucoma primario de ángulo abierto es el tipo más común y representa la segunda causa de ceguera irreversible, por lo que es una enfermedad compleja y heterogénea.Objetivo: caracterizar de forma clínica a los pacientes atendidos en la consulta provincial de glaucoma de Pinar del Río, durante el periodo enero 2017 a diciembre del 2018.Métodos: estudio transversal, descriptivo. Se examinaron 1 447 pacientes en la consulta provincial de glaucoma, con el diagnóstico de glaucoma primario de ángulo abierto, en el periodo enero 2017- diciembre del 2018.Resultados: el 67,3 % de los pacientes estudiados pertenecieron al grupo etario de 60-80 años de edad y el 70 % eran del sexo masculino. El 37,8 % tenían un color de la piel mestizo. El 68,7 % presentaron un glaucoma leve y el 89,8 % tenían una agudeza visual entre 1,0-0,3. El 68,7 % de los pacientes tenían una tensión ocular por debajo de 21 mmHg. El 75,2 % de los pacientes tenían un tiempo de evolución de la enfermedad de más de cinco años y el 89,4 % llevaba tratamiento médico.Conclusiones: el glaucoma primario de ángulo abierto fue más frecuente en edades avanzadas, en el sexo masculino y en los mestizos. La mayoría tenía buena agudeza visual mejor corregida en su mejor ojo y tensiones oculares normales. Prevaleció el glaucoma leve, con un tiempo de evolución de más de cinco años y con tratamiento médico para el control de la enfermedad

Gamma-ray observations of MAXI J1820+070 during the 2018 outburst

International audienceMAXI J1820+070 is a low-mass X-ray binary with a black hole as a compact object. This binary underwent an exceptionally bright X-ray outburst from March to October 2018, showing evidence of a non-thermal particle population through its radio emission during this whole period. The combined results of 59.5 hours of observations of the MAXI J1820+070 outburst with the H.E.S.S., MAGIC and VERITAS experiments at energies above 200 GeV are presented, together with Fermi-LAT data between 0.1 and 500 GeV, and multiwavelength observations from radio to X-rays. Gamma-ray emission is not detected from MAXI J1820+070, but the obtained upper limits and the multiwavelength data allow us to put meaningful constraints on the source properties under reasonable assumptions regarding the non-thermal particle population and the jet synchrotron spectrum. In particular, it is possible to show that, if a high-energy gamma-ray emitting region is present during the hard state of the source, its predicted flux should be at most a factor of 20 below the obtained Fermi-LAT upper limits, and closer to them for magnetic fields significantly below equipartition. During the state transitions, under the plausible assumption that electrons are accelerated up to ~ 500 GeV, the multiwavelength data and the gamma-ray upper limits lead consistently to the conclusion that a potential high-energy and very-high-energy gamma-ray emitting region should be located at a distance from the black hole ranging between 10^11 and 10^13 cm. Similar outbursts from low-mass X-ray binaries might be detectable in the near future with upcoming instruments such as CTA

Gamma-ray observations of MAXI J1820+070 during the 2018 outburst

MAXI J1820+070 is a low-mass X-ray binary with a black hole (BH) as a compact object. This binary underwent an exceptionally bright X-ray outburst from 2018 March to October, showing evidence of a non-thermal particle population through its radio emission during this whole period. The combined results of 59.5 h of observations of the MAXI J1820+070 outburst with the H.E.S.S., MAGIC and VERITAS experiments at energies above 200 GeV are presented, together with Fermi-LAT data between 0.1 and 500 GeV, and multiwavelength observations from radio to X-rays. Gamma-ray emission is not detected from MAXI J1820+070, but the obtained upper limits and the multiwavelength data allow us to put meaningful constraints on the source properties under reasonable assumptions regarding the non-thermal particle population and the jet synchrotron spectrum. In particular, it is possible to show that, if a high-energy (HE) gamma-ray emitting region is present during the hard state of the source, its predicted flux should be at most a factor of 20 below the obtained Fermi-LAT upper limits, and closer to them for magnetic fields significantly below equipartition. During the state transitions, under the plausible assumption that electrons are accelerated up to ∼500 GeV, the multiwavelength data and the gamma-ray upper limits lead consistently to the conclusion that a potential HE and very-HE gamma-ray emitting region should be located at a distance from the BH ranging between 1011 and 1013 cm. Similar outbursts from low-mass X-ray binaries might be detectable in the near future with upcoming instruments such as CTA

Gamma-ray observations of MAXI J1820+070 during the 2018 outburst

Abstract MAXIJ1820+070 is a low-mass X-ray binary with a black hole (BH) as a compact object. This binary underwent an exceptionally bright X-ray outburst from 2018 March to October, showing evidence of a non-thermal particle population through its radio emission during this whole period. The combined results of 59.5 h of observations of the MAXI J1820+070 outburst with the H.E.S.S., MAGIC and VERITAS experiments at energies above 200 GeV are presented, together with Fermi-LAT data between 0.1 and 500 GeV, and multiwavelength observations from radio to X-rays. Gamma-ray emission is not detected from MAXI J1820+070, but the obtained upper limits and the multiwavelength data allow us to put meaningful constraints on the source properties under reasonable assumptions regarding the non-thermal particle population and the jet synchrotron spectrum. In particular, it is possible to show that, if a high-energy (HE) gamma-ray emitting region is present during the hard state of the source, its predicted flux should be at most a factor of 20 below the obtained Fermi-LAT upper limits, and closer to them for magnetic fields significantly below equipartition. During the state transitions, under the plausible assumption that electrons are accelerated up to similar to 500 GeV, the multiwavelength data and the gamma-ray upper limits lead consistently to the conclusion that a potential HE and very-HE gamma-ray emitting region should be located at a distance from the BH ranging between 10¹¹ and 10¹³ cm. Similar outbursts from low-mass X-ray binaries might be detectable in the near future with upcoming instruments such as CTA

Searching for VHE gamma-ray emission associated with IceCube neutrino alerts using FACT, H.E.S.S., MAGIC, and VERITAS

The realtime follow-up of neutrino events is a promising approach to search for astrophysical neutrino sources. It has so far provided compelling evidence for a neutrino point source: the flaring gamma-ray blazar TXS 0506+056 observed in coincidence with the high-energy neutrino IceCube-170922A detected by IceCube. The detection of very-high-energy gamma rays (VHE, E&gt;100GeV E &gt; 100 G e V ) from this source helped establish the coincidence and constrained the modeling of the blazar emission at the time of the IceCube event. The four major imaging atmospheric Cherenkov telescope arrays (IACTs) - FACT, H.E.S.S., MAGIC, and VERITAS - operate an active follow-up program of target-of-opportunity observations of neutrino alerts sent by IceCube. This program has two main components. One are the observations of known gamma-ray sources around which a cluster of candidate neutrino events has been identified by IceCube (Gamma-ray Follow-Up, GFU). Second one is the follow-up of single high-energy neutrino candidate events of potential astrophysical origin such as IceCube-170922A. GFU has been recently upgraded by IceCube in collaboration with the IACT groups. We present here recent results from the IACT follow-up programs of IceCube neutrino alerts and a description of the upgraded IceCube GFU system